✦ LIBER ✦

Objective measurement of bladder sensation: use of a new patient-activated device and response to neuromodulation

✍ Scribed by Michael D. Craggs

Book ID: 109051925
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 252 KB
Volume: 96
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2005.05649.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The assessment of depression inventory (

The assessment of depression inventory (ADI): A new instrument used to measure depression and to detect honesty of response

✍ Neil L. Mogge; James P. LePage 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 1 views

A prospective study using rhinomanometry

A prospective study using rhinomanometry and patient clinical satisfaction to determine if objective measurements of nasal airway resistance can improve the quality of septoplasty

✍ J. Sipilä; J. Suonpää 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 458 KB

Safety and tolerability of a modified fi

Safety and tolerability of a modified filter-type device for leukocytapheresis using ACD-A as anticoagulant in patients with mild to moderately active ulcerative colitis. Results of a pilot study

✍ Vladislaw Muratov; Joachim Lundahl; Aleksandra Mandic-Havelka; Kerstin Elvin; Åk 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract Cellsorba™ is a medical device for leukocytapheresis (LCAP) treatment of ulcerative colitis (UC). Cellsorba™ EX Global type has been developed from Cellsorba E for intended use with ACD‐A as anticoagulant. We evaluated safety and efficacy of the modified Cellsorba using ACD‐A in a pilot

Influence of baseline hemodynamic status

Influence of baseline hemodynamic status and sympathetic activity on the response to nicardipine, a new dihydropyridine, in patients with hypertension or chronic congestive heart failure

✍ Ryman, Kathleen S; Kubo, Spencer H; Shaknovich, Alexander; Cody, Robert J 📂 Article 📅 1987 🏛 Nature Publishing Group 🌐 English ⚖ 515 KB

High rate of clinical complete response

High rate of clinical complete response to weekly outpatient neoadjuvant chemotherapy in oral carcinoma patients using a new regimen of cisplatin, 5-fluorouracil, and bleomycin alternating with methotrexate and epirubicin

✍ Jin-Ching Lin; Jian-Sheng Jan; Chen-Yi Hsu; Daniel Yong-Kie Wong 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 2 views

A Phase II trial was initiated to evaluate the response to and toxicity of a new regimen of weekly outpatient neoadjuvant chemotherapy in patients with oral carcinoma. ## METHODS. Patients with previously untreated squamous cell carcinoma of the oral cavity were eligible for this trial. The neoad